Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 134

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 134
---
 us for damages caused to us as a result
of a breach of duty of care, and undertaking to indemnify each of them to the fullest extent permitted by law, to the extent that these
liabilities are not covered by directors’ and officers’ liability insurance. The terms of these agreements and of our directors’
and officers’ liability insurance are consistent with the provisions of the Compensation Policy. See “ Item 6. C - 
Directors, Senior Management and Employees - Board Practices - Exculpation, insurance and indemnification of office holders.”

Compensation of Directors and Senior Management

The following table presents in the aggregate all compensation
we paid to all of our directors and senior management as a group for the year ended December 31, 2024. The table does not include any
amounts we paid to reimburse any such persons for costs incurred in providing us with services during this period.

                                                                                Salaries, fees,                                 Pension,                         
                                                                                (in thousands of U. S. dollars)                                                  
  All directors and senior management as a group, consisting of 13 persons                                           1,912                                  899  

The following table presents information regarding the compensation costs of our four
executive officers in the year ended December 31, 2024. All amounts reported reflect the cost to the Company as recognized in our financial
statements for the year ended December 31, 2024.

  Name and Position                             Salary                                                                                 
                                                (in thousands of U. S. dollars)                                                        
  Philip A. Serlin                                                                   296      109       74      265       20      764  
  Mali Zeevi                                                                         195       59       49       32       22      357  
  Ella Sorani                                                                        221       54        -       32       20      328  
  Holly W. May                                                                       440       61      226        -      220      947  

* Ms. May ceased to serve as President of BioLineRx USA, Inc.
on December 31, 2024.

  (1)      “ Social Benefits” include payments to the National Insurance Institute,                                                        

  (2)      With the exception of Ms. May, does not include annual bonuses for 2024, which remain    
  (3)      Consists of amounts recognized as share-based compensation expense on the Company’s      

  (4)      “ All Other Compensation” includes automobile-related expenses pursuant to the Company’s